These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18023706)

  • 1. Thromboprophylaxis during chemotherapy after advanced cancer.
    Agnelli G; Verso M
    Thromb Res; 2007; 120 Suppl 2():S128-32. PubMed ID: 18023706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboprophylaxis during chemotherapy in patients with advanced cancer.
    Agnelli G; Verso M
    Thromb Res; 2010 Apr; 125 Suppl 2():S17-20. PubMed ID: 20433999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
    Agnelli G; George DJ; Kakkar AK; Fisher W; Lassen MR; Mismetti P; Mouret P; Chaudhari U; Lawson F; Turpie AG;
    N Engl J Med; 2012 Feb; 366(7):601-9. PubMed ID: 22335737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer and venous thromboembolism].
    Meyer G; Belmont L
    Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism and cancer: a two-way clinical association.
    Agnelli G
    Thromb Haemost; 1997 Jul; 78(1):117-20. PubMed ID: 9198139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thromboembolism in cancer patients.
    Kakkar AK; Williamson RC
    Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
    Agnelli G; Gussoni G; Bianchini C; Verso M; Mandalà M; Cavanna L; Barni S; Labianca R; Buzzi F; Scambia G; Passalacqua R; Ricci S; Gasparini G; Lorusso V; Bonizzoni E; Tonato M;
    Lancet Oncol; 2009 Oct; 10(10):943-9. PubMed ID: 19726226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
    Ansell JE
    Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of anticoagulation in the management of pancreatic cancer.
    Sohail MA; Saif MW
    JOP; 2009 Mar; 10(2):82-7. PubMed ID: 19287098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
    Prandoni P; Samama MM
    Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in cancer patients undergoing major surgery.
    Osborne NH; Wakefield TW; Henke PK
    Ann Surg Oncol; 2008 Dec; 15(12):3567-78. PubMed ID: 18841419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
    ten Cate-Hoek AJ; Prins MH
    Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer and venous thromboembolism].
    Meyer G
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S42-7. PubMed ID: 22177769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation in the treatment of established venous thromboembolism in patients with cancer.
    Lee AY
    J Clin Oncol; 2009 Oct; 27(29):4895-901. PubMed ID: 19738121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy.
    Levine MN
    Thromb Haemost; 1997 Jul; 78(1):133-6. PubMed ID: 9198142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New agents in medical oncology and the risk of venous thromboembolism.
    Manzoni M; Bencardino K; Piovella F; Chatzileontiadou S; Delfanti S; Riccardi A; Danova M; Corazza GR
    J Exp Clin Cancer Res; 2007 Jun; 26(2):185-94. PubMed ID: 17725097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.